Anixa Biosciences Inc. (NASDAQ: ANIX) Stock Information | RedChip

Anixa Biosciences Inc. (NASDAQ: ANIX) Listen to this Section


$3.20
+0.1000 ( +3.23% ) 48.0K

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Market Data


Open


$3.20

Previous close


$3.10

Volume


48.0K

Market cap


$102.10M

Day range


$3.15 - $3.24

52 week range


$2.15 - $5.13

Insider Ownership Transactions

Total Amount Purchased: 72,976.00 | $ 233,523.20

Date Type Amount Purchased Purchaser
2024-08-01 Buy 21646.00 Titterton Lewis H jr
2024-07-29 Buy 796.00 Titterton Lewis H jr
2024-07-26 Buy 5000.00 Baskies Arnold M
2024-06-18 Buy 4000.00 Titterton Lewis H jr
2024-06-14 Buy 405.00 Titterton Lewis H jr
2024-06-12 Buy 330.00 Titterton Lewis H jr
2024-06-10 Buy 10738.00 Titterton Lewis H jr
2024-06-07 Buy 25000.00 KUMAR AMIT
2024-06-07 Buy 6250.00 Catelani Michael
2024-05-02 Sale -1189.00 Catelani Michael

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Aug 01, 2024
4 Insider transactions 1 Jul 29, 2024
4 Insider transactions 1 Jul 26, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 12, 2024
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
10-q Quarterly Reports 65 Jun 04, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.